Entering text into the input field will update the search result below

Brainstorm KOL event today on NurOwn in Alzheimer's

  • Brainstorm Cell Therapeutics (NASDAQ:BCLI) will host a Key Opinion Leader (KOL) webinar today at 8:15 am ET on its program in Alzheimer's disease (AD).
  • It recently announced its plan to develop NurOwn in AD. A Phase 2 clinical trial is next up.

Recommended For You

About BCLI Stock

SymbolLast Price% Chg
Market Cap
PE
Yield (TTM)
Rev Growth (YoY)
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
BCLI--
Brainstorm Cell Therapeutics Inc.